Stephanie Parks, DPM
Foot & Ankle Surgery · Albuquerque, NMNPI 1760747844
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Smith+Nephew at 24.3% of the total. 2025 is the largest year on record at $1,096, 2.2 times the $496 reported in 2019.
Across 171 payments — averaging $24.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$1K
- Stryker$910
- Kerecis Limited$811
- Organogenesis Inc.$304
- Integra Lifesciences Corporation$284
- Orthofix Medical, Inc.$128
- plus $752 from 14 others
What the payments were for
- Food & beverage$3,96894%
- Other$2486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 56 | $1,026 |
| Stryker(2 entities) | 32 | $910 |
| Kerecis Limited | 22 | $811 |
| Organogenesis Inc. | 14 | $304 |
| Integra Lifesciences Corporation | 4 | $284 |
| Orthofix Medical, Inc. | 12 | $128 |
| Paratek Pharmaceuticals, Inc. | 6 | $120 |
| Cardiovascular Systems Inc. | 1 | $109 |
| Medical Device Business Services, Inc. | 1 | $77 |
| Reprise Biomedical, Inc. | 6 | $76 |
| Osiris Therapeutics Inc. | 2 | $64 |
| Medtronic | 2 | $52 |
| Bioventus LLC | 3 | $51 |
| Treace Medical Concepts, Inc. | 3 | $51 |
| Mimedx Group, Inc. | 2 | $40 |
| Convatec Inc. | 1 | $36 |
| Nevro Corp. | 1 | $29 |
| Biocomposites Inc | 1 | $18 |
| KCI USA, Inc. | 1 | $15 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,215 in reported general payments places this provider in the 65th percentile of 69 foot & ankle surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 26 | $722 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $295 |
| Doxycycline Hyclate | 11 | $195 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $123 |
| Gabapentin | 14 | $112 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Albuquerque
- Mark MargiottaAlbuquerque$12K
- Jason DunnAlbuquerque$10K
- Alexander JenksAlbuquerque$9K
- Marshall MonsonAlbuquerque$9K
- Chad SmithAlbuquerque$9K
- Mark TennyAlbuquerque$8K
- Eve HuiAlbuquerque$6K
- Haywan ChiuAlbuquerque$5K
- Steven WregeAlbuquerque$4K
- Shama PervaizAlbuquerque$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.